This is our Regulatory Landscape newsletter for February 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of January there were over 90 new Regulatory job postings at small and mid-sized biotech and pharma companies across the country. This is in addition to the 500+ Regulatory roles that are[…]
Nearly two years into the pandemic-driven shift in how (and where) we work, employees have made it abundantly clear that they are seeking greater flexibility and autonomy from their employers – and they’re finally getting it. The ability to work some days at home and some days in the office (a hybrid model) or working[…]
Happy New Year and I hope you all enjoyed the holidays. This is our Regulatory Landscape newsletter for January 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of December there were about 75 new Regulatory job postings at small and mid-sized biotech and pharma companies across the country. […]
Companies across the US are all too familiar with current hiring challenges: too many open roles and not enough qualified candidates. Fueled by “the Great Resignation” and a pandemic-era shift in priorities, along with a surge of new biotech companies and record IPOs, Regulatory Affairs job openings are at an all-time high. We are seeing[…]
This is our July 2021 Regulatory Landscape newsletter with monthly insights on the evolving market for regulatory professionals. In June we saw over 150 new Regulatory roles at smaller and mid-sized biotech and pharma companies. This doesn’t include Regulatory positions at Big Pharma companies, Medical Device or Diagnostics firms. As usual, most of these were[…]
As the post-pandemic job market continues to boom, much of the conversation dominating 2021 is around what experts are calling, “The Great Resignation”. This phrase was coined by associate management professor Anthony Klotz of Texas A&M University during a recent Bloomberg Businessweek interview; “’When there’s uncertainty, people tend to stay put, so there are pent-up[…]
This is our June 2021 Regulatory Landscape newsletter with monthly insights on the market for regulatory professionals. In May we saw over 125 new Regulatory roles posted at smaller and mid-sized biotech and pharmaceutical companies. The majority of these were Regulatory Strategy roles at the Associate Director, Director, and Senior Director levels. There were also[…]
This is our May 2021 Regulatory Landscape newsletter with monthly insights on the market for regulatory professionals. After a very strong March, the Regulatory job market has calmed a bit as we enter Q2. In April we saw over 100 new regulatory roles posted at smaller and mid-sized biotech and pharmaceutical companies which was a[…]
This is our April 2021 Regulatory Landscape newsletter with monthly insights on the market for regulatory professionals. The Regulatory job market continues to heat up! In the first quarter of 2021, Regulatory openings at small to mid-sized biopharma companies saw a 95% increase over the 4th quarter of 2020! This includes a 400% increase in[…]
Last October, we surveyed over 400 biotech and pharmaceutical professionals to learn if and when they were planning to return to their workplace in-person, as well as if and when they’d feel comfortable doing so. At that time, approximately 30% of respondents did not know when they’d return and 61% said they would not feel[…]
